Filter posts

Report Shows World's Weakest IP Environments

There is clear link between a country’s rate of economic development and the strength of …

BIO Responds to GPhA Citizen Petition on Biosimilars Naming

Last September, the Generic Pharmaceutical Association (GPhA) filed a Citizen Petition with the FDA, requesting …

BIO CEO Company Snapshot: Tetraphase Pharmaceuticals

The BIO CEO & Investor Conference is now just a week away, and buzz for …

Life Science Leader on TransCelerate’s Efforts to Modernize Drug Development

Life Science Leader’s Rob Wright has a great profile on TransCelerate BioPharma and their efforts …

2013 Novel Drug Approvals

The FDA approved 24 novel drugs last year by our count, in line with average …

BIO Submits Comments to the EPA’s 2014 RVO Proposed Rule

The public comment period for the Environmental Protection Agency’s (EPA) 2014 proposal on the Renewable …